Public Sector Pension Investment Board Has $7.58 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Public Sector Pension Investment Board decreased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 105,129 shares of the company’s stock after selling 4,700 shares during the quarter. Public Sector Pension Investment Board owned 0.21% of Prestige Consumer Healthcare worth $7,580,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare during the 2nd quarter worth about $26,000. Quest Partners LLC boosted its stake in shares of Prestige Consumer Healthcare by 2,826.7% in the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after purchasing an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Gladius Capital Management LP bought a new position in shares of Prestige Consumer Healthcare in the 2nd quarter valued at about $35,000. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 562.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after purchasing an additional 433 shares during the last quarter. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE:PBH opened at $84.77 on Friday. The company has a market capitalization of $4.19 billion, a price-to-earnings ratio of 20.63, a P/E/G ratio of 2.37 and a beta of 0.47. The firm’s 50 day simple moving average is $75.41 and its 200 day simple moving average is $71.16. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $86.36.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.09. The business had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. Prestige Consumer Healthcare’s revenue for the quarter was down .9% on a year-over-year basis. During the same period last year, the company posted $1.07 EPS. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on PBH. Jefferies Financial Group reaffirmed a “hold” rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reaffirmed a “buy” rating and issued a $95.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $83.67.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, insider William P’pool sold 8,987 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total transaction of $735,585.95. Following the sale, the insider now directly owns 20,058 shares in the company, valued at approximately $1,641,747.30. This trade represents a 30.94 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mary Beth Fritz sold 9,885 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total transaction of $810,273.45. Following the sale, the senior vice president now owns 18,835 shares in the company, valued at $1,543,904.95. This trade represents a 34.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 38,810 shares of company stock worth $3,187,300. Company insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.